Results 71 to 80 of about 8,893 (235)

Cardiometabolic improvements, sleep apnea reduction, and biomarker modulation under dual GLP-1RA and SGLT2i therapy: a prospective study [PDF]

Pharmacia
This prospective cohort study explored the cardiometabolic, sleep-related, and biomarker effects of glucagon-like peptide-1 receptor agonists (GLP-1RA), sodium–glucose cotransporter-2 inhibitors (SGLT2i), and their combination in patients with heart ...
Petar Kalaydzhiev, Tsvetelina Velikova, Gergana Voynova, Radostina Ilieva, Natalia Spasova, Slavi Yakov, Elena Kinova, Georgi H. Vasilev, Radosveta Wells, Assen Goudev   +9 more
doaj   +3 more sources

Risk of acute pancreatitis with DPP‐4 inhibitors versus SGLT2 inhibitors in medication‐naïve individuals with diabetes: A target trial emulation

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims We investigated whether dipeptidyl peptidase‐4 inhibitor (DPP‐4i) use was associated with a higher risk of acute pancreatitis compared with sodium–glucose cotransporter 2 inhibitor (SGLT2i) use in antidiabetic medication‐naïve individuals.
Takashi Tatewaki, Akira Okada, Yuya Kimura, Hideo Yasunaga   +3 more
wiley   +1 more source

Rethinking control‐IQ+ technology: Simple strategies for easy optimization

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Control‐IQ+ is an automated insulin delivery (AID) algorithm approved for people with type 1 diabetes aged 2+ years and adults aged 18+ years with type 2 diabetes. While numerous publications support improved glycaemia and quality of life for people with diabetes, this practice paper is intended to encourage uptake for healthcare professionals
Viral N. Shah, Pratik Choudhary, Ilana Halperin, Ivana Rabbone, Dessi P. Zaharieva, Laurel Messer   +5 more
wiley   +1 more source

Comparative effectiveness of pharmacotherapy for heart failure with preserved ejection fraction: A systematic review and network meta‐analysis

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Heart failure with preserved ejection fraction (HFpEF) presents a therapeutic challenge, characterised by a paucity of validated treatments. Emerging data suggest that targeting adiposity is central to HFpEF pathogenesis. We conducted an updated network meta‐analysis to compare the efficacy of emerging and established HFpEF therapies ...
Szu‐Han Chen, Yu‐Wen Tseng, Chi‐Jung Huang, Shu‐Mei Yang, Marat Fudim, Shao‐Yuan Chuang, Shih‐Hsien Sung, Hao‐Min Cheng   +7 more
wiley   +1 more source

An oral glucose tolerance test in pregnancy and its association with future cardiovascular diseases

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims/hypothesis Gestational diabetes and abnormal 100‐g oral glucose tolerance test (OGTT) results in pregnancy are associated with type 2 diabetes, but their relationship with cardiovascular disease (CVD) is less clear. We evaluated the risk of CVD according to the number of abnormal OGTT values during pregnancy.
Tal Schiller, Linoy Gabay, Oren Barak, Alena Kirzhner, Haitham Abu Khadija, Gabriel Chodick, Edi Vaisbuch, Yael Barer   +7 more
wiley   +1 more source

GLP‐1 Receptor Agonists for Obstructive Sleep Apnea: An Otolaryngologist's Prescription?

The Laryngoscope, EarlyView.
Alina Zgardau, Ryan Chin Taw Cheong, Kenny Peter Pang, Brian W. Rotenberg   +3 more
wiley   +1 more source

Providing holistic care for patients with metabolic dysfunction‐associated steatotic liver disease/metabolic dysfunction‐associated steatohepatitis: Key aspects of clinical assessment and how to develop individualised care plans for surveillance and interventions

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD), characterised by hepatic steatosis and metabolic dysfunction (i.e., obesity, type 2 diabetes, dyslipidaemia, and hypertension), is affecting over 30% of the adult population worldwide.
Lanlan Chen, Paul Horn, Frank Tacke
wiley   +1 more source

Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study [PDF]

, 2019
Aims According to cardiovascular outcome trials, some sodium-glucose contransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) are recommended for secondary cardiovascular prevention in type 2 diabetes (T2D).
Achiropita Pucci, Adriano Gatti, Agostino Consoli, Alessandra Dei Cas, Anna Solini, Annunziata Lapolla, Antonino Di Benedetto, Antonio Carlo Bossi, Arena, Salvatore, Avogaro Angelo, Berchialla, Paola, Bottigliengo, Daniele, Bruno Fattor, Buzzetti, Raffaella, Carla Giordano, Carlo Mannina, Carmela Vinci, D'Angelo, Paola, Edoardo Duratorre, Eleonora Devangelio, Emanuela Orsi, Enzo Bonora, Fabrizio Querci, Fadini, Gian Paolo, Federica D'Angelo, Francesco Andreozzi, Franco Cavalot, Franzetti, Ivano, Gaetano Leto, Gian Pio Sorice, Gianluca Aimaretti, Giorgio Sesti, Giovanni Grossi, Giuliana Cazzetta, Giuseppe Capobianco, Giuseppe Felace, Giuseppe Penno, Giuseppe Saglietti, Gloria Formoso, Ioannis Karamouzis, Ivana Zavaroni, Ivano Franzetti, Lucia Frittitta, Manfredi Rizzo, Massimiliano Petrelli, Massimo Boemi, Massimo Cigolini, Maurizio Poli, Natalino Simioni, Nino Cristiano Chilelli, Olga Lamacchia, Paola D'Angelo, Paola Silvia Morpurgo, Patrizia Li Volsi, Raffaella Buzzetti, Riccardo Bonadonna, Roberta Chianetta, Roberto Anichini, Salvatore Arena, Salvatore Piro, Sciannameo, Veronica, Silvestre Cervone, Susanna Morano, Vera Frison, Vinci, Carmela   +64 more
core   +1 more source

Impact of Glucagon-Like Peptide-1 Receptor Agonists on Postoperative Outcomes Following Ankle Fracture Open Reduction and Internal Fixation

Foot & Ankle Orthopaedics
Research Type: Level 3 - Retrospective cohort study, Case-control study, Meta-analysis of Level 3 studies Introduction/Purpose: Glucagon-like peptide-1 receptor agonists (GLP-1RA) are quickly growing in popularity as effective tools in the management of ...
Joshua Morningstar BS, Bradley Lauck BA, Nicholas Bank MD, Trapper Lalli MD   +3 more
doaj   +1 more source

Use of GLP-1 receptor agonists and risks of suicide attempts or self-harm in patients with type 2 diabetes: a multicountry self-control case series study

BMJ Mental Health
Background Inconclusive findings regarding the association between suicidal ideation/suicide attempt and glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been recently revealed in a small number of studies.Methods This was a multinational self ...
Ian Chi Kei Wong, Eric Yuk Fai Wan, Huang-Tz Ou, Esther Wai Yin Chan, Vincent Ka Chun Yan, Zi-Yang Peng, Vincent Kai Chung Wong   +6 more
doaj   +1 more source